维普期刊资源整合服务平台（V6.5）

67篇 您的检索式：作者名="Morange M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Identification of polymorphisms in the promoter and the 3 ' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled显示文摘	Aubert H Morange PE	2001	Blood2001，97，7：	1
2	Plasma levels of free and total TFPI,relationship with cardiovascular risk factor and endothelial cell makers 显示文摘	Morange P E Renucci J F Charles M A	2001	Thromb Haemost2001，85，6：	1
3	PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level显示文摘	Morange PE Alessi MC Verdier M	1999	Arterioscler Thromb Vasc Biol1999，19，5：	1
4	Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infection 显示文摘	Morange PE Henry M Frere C	2002	Blood2002，99，5：	1
5	Thr325IIe polymor phism of the TAFI gene does not influence the risk of myocar dial infection显示文摘	Henry M Frere C	2002	Blood2002，99，5：	1
6	Diet modulates endogenous thrombin generation,a biological estimate of thrombosis risk,independently of the metabolic status显示文摘	SANCHEZ C POGGI M MORANGE PE	2012	Arterioscler Thromb Vasc Biol2012，32，10：	1
7	Genetic polymorphisms and coronary artery disease in South of France显示文摘	Canavy I Henry M Morange PE	2000	Thromb Haemost2000，83，：	1
8	Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled 显示文摘	Henry M Aubert H Morange PE	2001	Blood2001，97，7：	1
9	Recent advances inthe pharmacogenetics of clopidogrel 显示文摘	CUISSET T MORANGE P E ALESSI M C	2012	Hum Genet2012，131，5：	1
10	Plasminogen activator inhibitor 1,transforming growth factor-beta1,and BMI are closely associated in human adipose tissue during morbid obesity显示文摘	Alessi M C Bastelica D Morange P	2000	Diabetes2000，49，：	1
11	Identification of polymorphisms in the promoter and the 3'region of the TAFI gene:evidence that plasma TAFI antigen levels are strongly genetically controlled显示文摘	AUBER H MORANGE PE	2001	Blood2001，97，：	1
12	Prognostic value of plasma issue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study显示文摘	MORANGE P E BLANGKENBERG S ALESSI M C	2007	J Thromb Haemost2007，5，：	1
13	Genetic polymorphisms and coronary artery disease in South of France显示文摘	Canavy I Henry M Morange PE	2000	Thromb Haemost2000，83，：	1
14	PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level显示文摘	Morange PE Alessi MC Verdier M	1999	Arterioscler Thromb Vasc Biol1999，19，5：	1
15	Genetic polymorphisms and coronary artery disease in the south of France显示文摘	Canavy I Henry M Morange PE		0，，02：	1
16	PAI-1 produced exvivo by human adipose tissue is relevant to PAI-1 blood level显示文摘	Morange PE Alessi MC Verdier M	1999	Arterioscler Thromb Vasc Biol1999，19，：	1
17	Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes显示文摘	Davidson SM Morange M	2000	Dev Biol2000，218，2：	1
18	Genetic polymorphisms and coronary artery disease in the south of France显示文摘	Canavy I Henry M Morange PE	2003	Thromb Haemost2003，83，2：	1
19	Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes显示文摘	Davidson SM Morange M	2000	Dev Biol2000，218，2：	1
20	Identification of polymorphisms in the promoter and the 3' region of the TAFI gene;evidence that plasma TAFI antigen levels are strongly genetically controlled显示文摘	Henry M Aubert H Morange PE	2001	Blood2001，97，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示